↓ Skip to main content

Targeting BTK in CLL: Beyond Ibrutinib

Overview of attention for article published in Current Hematologic Malignancy Reports, April 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#43 of 432)
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news
1 news outlet
patent
1 patent
facebook
1 Facebook page

Citations

dimensions_citation
98 Dimensions

Readers on

mendeley
124 Mendeley
Title
Targeting BTK in CLL: Beyond Ibrutinib
Published in
Current Hematologic Malignancy Reports, April 2019
DOI 10.1007/s11899-019-00512-0
Pubmed ID
Authors

David A. Bond, Jennifer A. Woyach

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 124 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 124 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 15%
Student > Bachelor 16 13%
Student > Ph. D. Student 13 10%
Other 9 7%
Student > Doctoral Student 7 6%
Other 19 15%
Unknown 42 34%
Readers by discipline Count As %
Medicine and Dentistry 26 21%
Biochemistry, Genetics and Molecular Biology 22 18%
Chemistry 10 8%
Agricultural and Biological Sciences 7 6%
Pharmacology, Toxicology and Pharmaceutical Science 7 6%
Other 11 9%
Unknown 41 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 August 2021.
All research outputs
#2,932,987
of 23,144,579 outputs
Outputs from Current Hematologic Malignancy Reports
#43
of 432 outputs
Outputs of similar age
#64,961
of 349,298 outputs
Outputs of similar age from Current Hematologic Malignancy Reports
#1
of 8 outputs
Altmetric has tracked 23,144,579 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 432 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 349,298 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them